INSIGHTS HUB
From advancing home dialysis solutions to providing world-class research and data-driven insights, we tirelessly seek new ways to improve the quality of patients' lives. By sharing our collective ideas and innovations, we believe each of us can make an impact – and together we can change an industry. Visit our Insights Hub to hear from our thought leaders, data scientists, providers, and more.
-
Episode 39 | Measuring the Quality of Peritoneal Dialysis
Our goal as providers is to give our patients the absolute best care possible, and that means we continuously work to improve and measure the quality of care we provide. As we grow peritoneal dialysis, the care and treatment we provide patients should result in lower morbidity and the best outcomes. But to understand how to improve, we need to answer this question: How do we measure the quality of PD?
Our goal as providers is to give our patients the absolute best care possible, and that means we continuously work to improve and measure the quality of care we provide. As we grow peritoneal dialysis, the care and treatment we provide patients should result in lower morbidity and the best outcomes. But to understand how to improve, we need to answer this question: How do we measure the quality of PD?
-
Episode 38 | Korsuva for the Management of CKD-aP
A third of hemodialysis patients suffer from moderate to severe pruritus (or itching). For some, this can result in constant, unrelenting itching. Dr. Dinesh Chatoth, Associate Chief Medical Officer and Chair of the Pharmacy and Therapeutics Committee at Fresenius Kidney Care, joins Field Notes to discuss the condition and explore the ways Korsuva, a new FDA-approved medication, can help patients.
A third of hemodialysis patients suffer from moderate to severe pruritus (or itching). For some, this can result in constant, unrelenting itching. Dr. Dinesh Chatoth, Associate Chief Medical Officer and Chair of the Pharmacy and Therapeutics Committee at Fresenius Kidney Care, joins Field Notes to discuss the condition and explore the ways Korsuva, a new FDA-approved medication, can help patients.
-
Episode 37 | Growing Home Therapies through the Physician Home Champion Program
Dr. Kristin Corapi and Dr. Arley Diaz join Field Notes to talk about the importance and success of the Physician Home Champion program.
Dr. Kristin Corapi and Dr. Arley Diaz join Field Notes to talk about the importance and success of the Physician Home Champion program.
-
Field Notes Episode 36: Expanding FreseniusRx Pharmacy Services to Better Serve Patients with Michelle Nguyen, PharmD
FreseniusRx is expanding its services beyond just kidney care to include non-renal medications and will become a go-to pharmacy for our patients’ medications needs. Senior Director of Pharmacy Michelle Nguyen, PharmD explains how this will work and why it is so important to ensure successful medical management and adherence.
FreseniusRx is expanding its services beyond just kidney care to include non-renal medications and will become a go-to pharmacy for our patients’ medications needs. Senior Director of Pharmacy Michelle Nguyen, PharmD explains how this will work and why it is so important to ensure successful medical management and adherence.
-
Episode 39 | Measuring the Quality of Peritoneal Dialysis
Our goal as providers is to give our patients the absolute best care possible, and that means we continuously work to improve and measure the quality of care we provide. As we grow peritoneal dialysis, the care and treatment we provide patients should result in lower morbidity and the best outcomes. But to understand how to improve, we need to answer this question: How do we measure the quality of PD?
Our goal as providers is to give our patients the absolute best care possible, and that means we continuously work to improve and measure the quality of care we provide. As we grow peritoneal dialysis, the care and treatment we provide patients should result in lower morbidity and the best outcomes. But to understand how to improve, we need to answer this question: How do we measure the quality of PD?
-
Episode 38 | Korsuva for the Management of CKD-aP
A third of hemodialysis patients suffer from moderate to severe pruritus (or itching). For some, this can result in constant, unrelenting itching. Dr. Dinesh Chatoth, Associate Chief Medical Officer and Chair of the Pharmacy and Therapeutics Committee at Fresenius Kidney Care, joins Field Notes to discuss the condition and explore the ways Korsuva, a new FDA-approved medication, can help patients.
A third of hemodialysis patients suffer from moderate to severe pruritus (or itching). For some, this can result in constant, unrelenting itching. Dr. Dinesh Chatoth, Associate Chief Medical Officer and Chair of the Pharmacy and Therapeutics Committee at Fresenius Kidney Care, joins Field Notes to discuss the condition and explore the ways Korsuva, a new FDA-approved medication, can help patients.
-
Episode 37 | Growing Home Therapies through the Physician Home Champion Program
Dr. Kristin Corapi and Dr. Arley Diaz join Field Notes to talk about the importance and success of the Physician Home Champion program.
Dr. Kristin Corapi and Dr. Arley Diaz join Field Notes to talk about the importance and success of the Physician Home Champion program.
-
Field Notes Episode 36: Expanding FreseniusRx Pharmacy Services to Better Serve Patients with Michelle Nguyen, PharmD
FreseniusRx is expanding its services beyond just kidney care to include non-renal medications and will become a go-to pharmacy for our patients’ medications needs. Senior Director of Pharmacy Michelle Nguyen, PharmD explains how this will work and why it is so important to ensure successful medical management and adherence.
FreseniusRx is expanding its services beyond just kidney care to include non-renal medications and will become a go-to pharmacy for our patients’ medications needs. Senior Director of Pharmacy Michelle Nguyen, PharmD explains how this will work and why it is so important to ensure successful medical management and adherence.
-
Episode 37 | APOL1 research and its impact on the African American population of renal patients
Dr. Reshma Kewalramani, CEO of Vertex Pharmaceuticals discusses the company’s research into the underlying cause of APOL1-mediated kidney disease.
Dr. Reshma Kewalramani, CEO of Vertex Pharmaceuticals discusses the company’s research into the underlying cause of APOL1-mediated kidney disease.
-
Episode 36 | Cognitive Dysfunction in Kidney Disease
Nephrologist Mark Unruh, MD, discusses cognitive impairment in patients with Chronic kidney disease and his research to find targeted interventions to address these challenge
Nephrologist Mark Unruh, MD, discusses cognitive impairment in patients with Chronic kidney disease and his research to find targeted interventions to address these challenge
-
Episode 35 | Humacyte and its Humanitarian Aid to Ukraine
Dr. Laura Niklason, Founder and CEO of Humacyte, discusses this promising technology and its recent deployment as humanitarian aid for repairing vascular trauma in Ukraine.
Dr. Laura Niklason, Founder and CEO of Humacyte, discusses this promising technology and its recent deployment as humanitarian aid for repairing vascular trauma in Ukraine.
-
Episode 34 | 50th Anniversary of 1972 Medicare legislation
In this episode of GMO Dialogues, Robert Sepucha, CEO of InterWell health talks about how this legislation changed the trajectory of kidney disease care in the United States, and led to value-based care models of today.
In this episode of GMO Dialogues, Robert Sepucha, CEO of InterWell health talks about how this legislation changed the trajectory of kidney disease care in the United States, and led to value-based care models of today.